Results 121 to 130 of about 21,622 (232)

Results of node split models for the test of difference between direct and indirect effect in the analysis of primary outcomes of IPSS total score, Qmax, IPSS storage subscore and IPSS voiding subscore.

, 2014
Results of the node split model to assess the inconsistency by testing the difference between the direct effect and indirect effect. If the P-value is more than 0.05, it indicates that the difference between the direct effect and indirect effect was not ...
Sheng Li (107261), Zhe Meng (464162), Tao Liu (10785), Xiao Wang (19312), Xinghuan Wang (533787), Xinhua Zhang (342405)   +5 more
core   +1 more source

No Relationship Between the International Prostate Symptom Score and Post-Void Residual Volume in Primary Care

Research and Reports in Urology, 2020
HA Lammers, TAM Teunissen, H Bor, IS Smid, ALM Lagro-Janssen Radboudumc, Department of Primary and Community Care/Gender & Women’s Health, Nijmegen, the NetherlandsCorrespondence: HA LammersRadboudumc, Huispost 117, Postbus 9101, Nijmegen 6500 ...
Lammers HA, Teunissen TAM, Bor H, Smid IS, Lagro-Janssen ALM   +4 more
doaj  

Preoperative patients’ characteristics, operative procedures, and IPSS scores.

, 2016
Preoperative patients’ characteristics, operative procedures, and IPSS scores.
Hidenori Akaihata (2889959), Yoshiyuki Kojima (106826), Soichiro Ogawa (2889965), Kei Ishibashi (2889947), Yuichi Sato (209687), Nobuhiro Haga (2889944), Ken Aikawa (2889962), Junya Hata (2889956), Seiji Hoshi (2889950), Michihiro Yabe (2889953)   +9 more
core   +1 more source

IPSS Risk Score [PDF]

, 2020
openaire   +1 more source

Transparência das IPSS na Região Autónoma da Madeira: estudo empírico [PDF]

, 2018
Esta versão contém as críticas e sugestões do júri.Por imposição legal, as Instituições Privadas de Solidariedade Social (IPSS) necessitam de reforçar as exigências da transparência relativamente às atividades que realizam e aos recursos que utilizam. As
Ornelas, Tomásia Inês Moniz de
core  

Voiding dysfunction in patients with nasal congestion treated with pseudoephedrine: a prospective study

Drug Design, Development and Therapy, 2016
I-Hung Shao,1,* Chia-Chen Wu,2,* Hsiao-Jung Tseng,3 Ta-Jen Lee,2 Yu-Hsiang Lin,4 Yuan-Yun Tam5 1Division of Urology, Department of Surgery, Lotung Poh-Ai Hospital, Yilan County, 2Department of Otorhinolaryngology – Head and Neck Surgery, Linkou ...
Shao IH, Wu CC, Tseng HJ, Lee TJ, Lin YH, Tam YY   +5 more
doaj  

ASSESSMENT OF THE IPSS-M IN CHRONIC MYELOMONOCYTIC LEUKEMIA

Prognostication in chronic myelomonocytic leukemia (CMML) remains a challenge due to the biological complexity and variable clinical course of the disease. This study aimed to evaluate the prognostic utility of the International Prognostic Scoring System-
Monica del Rey, Jordi Vila, Cristina Notario Mc Donnell, Mireia Morgades, Felix Lopez-Cadenas, Blanca Xicoy, Luca Lanino, Torsten Haferlach, Laura Palomo, Ana Garcia-Feria, Manja Meggendorfer, Marta Pratcorona, Rosa Collado, Juan Carlos Caballero Berrocal, Helena Pomares, Carmen Loredo, Alejandro Avendaño, Sandra Castaño-Díez, Gerardo Aguilar-Monserrate, Esther Alonso, Neus Ruiz-Xiville, Lurdes Zamora, Teresa Bernal del Castillo, Estefania Cerezo, Mar Tormo, Marina Díaz-Beyá, Mariam Ibañez, Pilar Galán Alvarez, Juan Restrepo, Pamela Acha, Matteo Giovanni Della Porta, Jose Francisco Falantes-González, Marta Cabezón, Marisa Calabuig, Guillermo Ramil, Verónica Roldán-Galiacho   +35 more
core   +1 more source

IPSS Risk Category [PDF]

, 2020
openaire   +1 more source

Controlo interno numa IPSS

, 2013
A evolução das estruturas de apoio social levou a que as IPSS passassem a assumir um papel crucial no seio da sociedade portuguesa atual. Este trabalho de projeto visa abordar o controlo interno no quadro específico das instituições sem fins lucrativos, cuja missão faz apelo a uma estrutura organizativa e de controlo interno que, apoiando-se nos ...
openaire   +1 more source

Pre-transplant molecular international prognostic scoring system score reduction is not associated with improved outcomes in myelodysplastic syndromes. [PDF]

Blood Cancer J
Sakashita M, Kanda J, Hattori K, Hiramoto N, Kanemura N, Kasahara S, Watanabe M, Yoshihara S, Ichii M, Sezaki N, Tsuji M, Maeda T, Sasaki K, Kitano T, Miyahara Y, Kondo T, Sakata-Yanagimoto M, Takaori-Kondo A, Ogawa S, Nannya Y.   +19 more
europepmc   +1 more source